Hot Topics in Neurological Disorder Therapeutics and Technologies
June 22, 2021
- Lauren Martz, Senior Editor, Head, Translation and Clinical Development, BioCentury Inc.
- Sarah Bhagat, PhD, General Partner, Sofinnova Investments
- Ginger S. Johnson, PhD, Chief Executive Officer, Cello Health BioConsulting
- Norbert Riedel, PhD, Chief Executive Officer, Aptinyx Inc.
- Myung Shin, PhD, Executive Director and Head of Early Discovery Genetics, Genetics and Pharmacogenomics, Merck & Co., Inc.